arrow
P

Philipp Sievers

Ruprecht-Karls University Heidelberg
H指数:35
被引数:5,043

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional proteomic and phosphoproteomic profiling of routine FFPE CNS tumor tissue complements genomic and epigenomic characterization

常规FFPE CNS肿瘤组织的功能蛋白质组学和磷酸化蛋白质组学分析补充了基因组学和表观基因组学的表征

2026-09-250
OAAI
Neuronal precursor cell persistence in ganglioglioma is associated with extracellular matrix remodeling and immune cell infiltration

神经前体细胞在神经节胶质瘤中的持续存在与细胞外基质重塑和免疫细胞浸润相关

2026-08-100
OA
Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification

儿童及年轻起病型脑膜瘤存在不同的分子亚群,需采用年龄适应性的风险分层策略

2026-07-140
OAAI
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

Hetairos是一种基于组织学的人工智能模型,用于预测中枢神经系统肿瘤甲基化亚型

2026-06-100
OAAI
Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma

胶质神经元肿瘤伴神经细胞分化(GNTN):一种分子界定的肿瘤类型,曾被称为脑室外神经细胞瘤

2026-05-210
OAAI
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification

微环境确定的风险连续体可改善脑膜瘤的亚型,并揭示基于机器学习的肿瘤分类的决定因素

2026-02-090
OAAI
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

通过扩展的基于DNA甲基化的分类来推进CNS肿瘤诊断

2025-12-040
OAAI
Hetairos enables AI-based histopathological classification of CNS tumours

Hetairos 实现了基于 AI 的 CNS 肿瘤组织病理学分类

2025-11-010
OAAI
MACHINE LEARNING AND MULTI-OMIC ANALYSIS IDENTIFY A MICROENVIRONMENT-DRIVEN MENINGIOMA RISK CONTINUUM UNDERLYING MOLECULAR CLASSIFICATIONS

机器学习和多组学分析识别出一种由微环境驱动的、与分子分类相关的脑膜瘤风险连续体

2025-11-010
PRE
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, et al. 推进中枢神经系统肿瘤诊断,扩展基于DNA甲基化的分类方法。medRxiv. (2025). doi: 10.1093/neuonc/noaf201.1012

2025-11-010
OAAI
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas

作者更正:FGFR 突变和共突变的多样化景观表明儿童低级别胶质瘤中存在潜在的治疗策略

2025-10-090
OA
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells

脑膜瘤中的肿瘤相关巨噬细胞:一种优于T细胞获益的新型不良生存预后生物标志物

2025-10-090
OA
A INTEGRATIVE MULTIOMICS ANALYSIS IDENTIFIES TUMOR-ASSOCIATED MACROPHAGES AS NOVEL INDEPENDENT BIOMARKER FOR POOR SURVIVAL IN MENINGIOMAS

整合多组学分析确定了肿瘤相关巨噬细胞作为脑膜瘤不良预后的新型独立生物标志物

2025-10-010
OAAI
AI-BASED HISTOPATHOLOGICAL CLASSIFICATION OF CENTRAL NERVOUS SYSTEM TUMOURS

基于人工智能的中央神经系统肿瘤组织病理学分类

2025-10-010
OAAI
Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomas

对被诊断为粘液乳头型室管膜瘤的肿瘤谱系进行扩展

2025-09-300
OA
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma

MAPK激活的免疫抑制性髓系细胞群在儿童低级别胶质瘤中的空间分布图

2025-09-150
PRE
PLAG1 fusions define a third subtype of CNS embryonal tumor with PLAG family gene alteration

PLAG1融合定义了具有PLAG家族基因改变的中枢神经系统胚胎性肿瘤的第三种亚型

2025-08-020
OAAI